The cause and the pathogenesis of systemic sclerosis have not been well elucidated. Systemic sclerosis is characterised by vascular and microvascular abnormalities, excessive fibroblastic activity, and collagen deposition in numerous organs, which may be induced by immunological defects. 2 A wide range of B and T cell abnormalities has been described in this disease, including antinuclear antibodies, immune complexes, decreased number of circulating T lymphocytes, increased CD4+/CD8+ ratio with decreased number of CD8+ cells,3 and defective EpsteinBarr virus specific T cell regulation.4 Moreover, c-myc and c-myb proto-oncogenes expression, using RNA hybridisation techniques, is significantly increased in T but not in B lymphocytes from patients with systemic sclerosis compared with control subjects, suggesting an in vivo activation of T cells. 
The cause and the pathogenesis of systemic sclerosis have not been well elucidated. Systemic sclerosis is characterised by vascular and microvascular abnormalities, excessive fibroblastic activity, and collagen deposition in numerous organs, which may be induced by immunological defects. 2 A wide range of B and T cell abnormalities has been described in this disease, including antinuclear antibodies, immune complexes, decreased number of circulating T lymphocytes, increased CD4+/CD8+ ratio with decreased number of CD8+ cells,3 and defective EpsteinBarr virus specific T cell regulation. 4 Moreover, c-myc and c-myb proto-oncogenes expression, using RNA hybridisation techniques, is significantly increased in T but not in B lymphocytes from patients with systemic sclerosis compared with control subjects, suggesting an in vivo activation of T cells. 5 Studies have shown that CD4+ T cells are both phenotypically and functionally heterogeneous and can be clearly distinguished by monoclonal antibodies to CD29 and CD45RA antigens.6 7 The CD29 and CD45RA antigens are present on T lymphocytes, B lymphocytes, and some monocytes; about 400/o of peripheral blood lymphocytes from normal subjects are positive for each antigen. Within the CD4+ subset anti-CD29 and anti-CD45RA antibodies identify reciprocal subpopulations. CD4+CD45RA+ cells, although not directly suppressive, induce activation of CD8+ cells and suppress immunoglobulin production by B cells in response to pokeweed mitogen and specific antigen; thus they are designated as a suppressor inducer subset.6 CD4+CD45RA+ cells are preferentially activated through interactions with selfclass II major histocompatibility complex in the autologous mixed lymphocyte reaction,7 8 (13) years; mean (SD) disease duration 9 (7) years) and nine control subjects (four women, five men; age 49 (7) years) were studied. All patients satisfied the American Rheumatism Association preliminary criteria for classification of definite systemic sclerosis. " Table 1 shows the clinical characteristics of the patient with active (five patients) and inactive (seven patients) systemic sclerosis. All patients had stopped taking slow acting therapeutic agents for at least six months before the study. Control The mean (SEM) CD45RA/CD29 'calculated overlap' in CD4+ cells (defined as the sum of the percentages of CD4+ cells expressing either the CD45RA or the CD29 antigens) was significantly increased in patients (15-4 (5-9)) compared with controls (3-1 (2-6)) (p<0 05). The mean (SEM) calculated overlap in CD8+ cells (defined as the sum of the percentages of CD8+ cells expressing either the CD45RA or the CD29 antigens) was significantly higher in patients (62-3 (4-5)) than in controls (28-9 (6-7)) (p<0-01). Figures 1 and 2 show characteristic histograms of CD45RA+ and CD29+ cells in gated CD4+ and CD8+ subpopulations respectively in a control subject and in a patient with systemic sclerosis. The last profiles show mainly bright CD45RA and CD29 cells.
To analyse further the significance of the calculated overlap CD4+ and CD8+ cells from three patients with systemic sclerosis and four controls were purified by complement dependent cytotoxicity. These purified subpopulations were treated simultaneously with PE conjugated anti-CD45RA and FITC conjugated anti-CD29 monoclonal antibodies.
In purified CD4+ cells the mean (SEM) percentage ofdouble positive CD45RA+CD29+ cells was 9-2 (2-2) (range 3-13) in controls and 20-7 (2-2) (range [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] in patients with systemic sclerosis.
In purified CD8+ cells the mean (SEM) percentage ofdouble positive CD45RA+CD29+ cells was 25-2 (7-0) (range 5-37) in controls and 39-0 (6-3) (range 31-52) in patients with systemic sclerosis. Figure 3 shows the double positive CD45RA+CD29+ cells (upper right quadrant) in the purified CD4+ and CD8+ subpopulations from a patient with scleroderma. 
Discussion
In systemic sclerosis activated T cells in vivo have been demonstrated in the dermis and subcutaneous tissue,12 and in peripheral blood lymphocytes,'3 by means of activation markers (Ia, Tac, and transferrin receptor). Moreover, the increased early response of autologous mixed lymphocyte reaction,'4 increased interleukin-2 production by phytohaemagglutinin stimulated peripheral blood lymphocytes,'5 and increased helper activity" are different functional aspects of in vivo activation of T cells from patients with scleroderma. Our previous studies showing an increased expression of c-myc and c-myb proto-oncogenes in T lymphocytes from patients with systemic sclerosis are also consistent with an in vivo early activation of T cells. 5 Which T lymphocyte subsets are involved in this in vivo activation remains to be determined. The use of monoclonal antibodies to the two functional subsets recently described as helperinducer (CD29) and suppressor-inducer (CD45RA) might help to answer this question. Our results show a significant increase in the CD29+ subset in patients with systemic sclerosis compared with controls. The higher percentage of CD29+ cells concerns both CD4+ and CD8+ cells. The CD8+CD45RA+ population is also increased in patients with scleroderma. This increase is not related to the absolute number of circulating lymphocytes, which was similar in patients and controls, nor to the activity of the disease.
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